Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

Conditions: Non-small Cell Lung Cancer; Metastatic Non-Small Cell Lung Cancer; NSCLC; KRAS G12C; Metastatic Lung Cancer; Advanced Lung Carcinoma Interventions: Drug: BBO-8520; Drug: Pembrolizumab Sponsors: TheRas, Inc Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials